Abstract
BackgroundEphAs are a class of ephrin receptors that belong to the membrane-bound receptor tyrosine kinases group. Accumulating experimental evidence has shown that the EphA family is involved in tumor progression, namely in cell proliferation, invasiveness, and metastasis. EphAs are a promising target for anticancer therapy. However, their role in breast cancer (BC) is still not well understood.Materials and MethodsWe used a series of bioinformatic approaches to analyze the expression of the EphA family members and investigate their prognostic value in BC.ResultsLower expression levels of EphA2, EphA3, EphA4, EphA5, and EphA7 and higher expression levels of EphA10 were found in BC tissues compared to those in normal tissues. The expression levels of the EphA family genes were correlated with molecular subtyping but not with tumor stage. High expression levels of most EphAs indicated a better prognosis in BC.ConclusionsThis study suggested that EphA2, EphA3, EphA4, and EphA5 can act as tumor-inhibiting factors as well as biomarkers for the prognosis of BC.
Reference39 articles.
1. Cancer Statistics, 2019;Siegel;CA: Cancer J Clin,2019
2. Eph-Ephrin Bidirectional Signaling in Physiology and Disease;Pasquale;Cell,2008
3. Repelling Class Discrimination: Ephrin-A5 Binds to and Activates EphB2 Receptor Signaling;Himanen;Nat Neurosci,2004
4. Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival;Kinch;Clin Cancer Res an Off J Am Assoc Cancer Res,2003
5. EPHA2/EFNA1 Expression in Human Gastric Cancer;Nakamura;Cancer science,2005
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献